Abstract
Opioid receptors were originally conceived as specific sites in the CNS that form a crucial link in the mechanism of pain perception and that fail to function in this respect when bound to certain ligands termed analgesics or analgetics. Substances that block the action of such opioid agonists ligands in a competitive manner were termed opioid antagonists and the two classes of ligand were assumed to compete for the same receptor. Up to the early 1970s there was no direct evidence of opioid receptors; speculations on their existence rested upon classical pharmacology (specificity of action and structure activity analyses, especially stereochemical, of agonists) and the identification of specific antagonists. Over the last 10 years or so, however, the application of radioactive labeled ligands to binding studies and autoradiography has yielded a large body of direct evidence and provided information about the location and general chemical nature of the receptors. Complementary to this evidence and of crucial support to the existence of opioid receptors was, undoubtedly, the discovery and identification of endogenous ligands (enkephalins, endorphins, etc.) since it was inconceivable that such receptors should have evolved on the off chance of interactions with exogenous ligands.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. H. Snyder, J. Med. Chem. 26, 1667 (1983).
L. E. Robson, S. J. Paterson, and H. W. Kosterlitz, Handbook Psychopharmacol. 17, 13 (1983).
J. A. Glasel and R. F. Venn, in: Current Methods in Cellular Neurobiology (J. Barker and J. F. McKelvy, eds.), Wiley, New York (1982).
C. B. Pert and S. H. Snyder, Science 179, 1011 (1973).
L. Terenius, J. Pharm. Pharmacol 26, 146 (1974).
J. Magnan, S. J. Paterson, A. Tavani, and H. W. Kosterlitz, Naunyn-Schmiedeberg-s Arch. Pharmacol 319, 197 (1982).
S. H. Snyder, G. W. Pastenak, and C. B. Pert, Handbook Psychopharmacol 5, 329 (1975).
G. W. Pasternak and S. R. Childers, in: Recent Advances in Clinical Pharmacology, (P. Turner and D. G. Shand, eds.), p. 257, Churchill Livingstone, Edinburgh (1983).
M. J. Kuhar, Handbook Psychopharmacol 15, 299 (1982), and refs. there cited.
S. F. Atweh and M. J. Kuhar, Brain Res. 124, 53 (1977).
S. F. Atweh and M. J. Kuhar, Brain Res. 129, 1 (1977).
S. F. Atweh and M. J. Kuhar, Brain Res. 134, 393 (1977).
C. B. Pert, M. J. Kuhar, and S. H. Snyder, Life Sci. 16, 1849 (1975).
G. Uhl, R. R. Goodman, M. J. Kuhar, S. R. Childers, and S. H. Snyder, Brain Res. 116, 75 (1979).
S. J. Watson, H. Akil, S. Sullivan, and J. D. Barchas, Life Sci. 21, 773 (1977).
R. Simantov, M. J. Kuhar, G. R. Uhl, and S. H. Snyder, Proc. Natl Acad. Sci. USA 74, 2167 (1977).
M. E. Phelps, D. E. Kuhl, and J. D. Mazzlotta, Science 211, 1445 (1981).
K. C. Rice, P. E. Konicki, R. Quirion, T. R. Burke, Jr., and C. B. Pert, J. Med. Chem. 26, 1643 (1983).
D. Y. Shirachi, S. L. Chan, and A. Trevor, in: Guide to Molecular Pharmacology-Toxicology (R. M. Featherstone, ed.), Vol. 1, p. 147, Dekker, New York (1973).
R. J. Miller, in: Cellular Receptors (D. Schulster and A. Levitzki, eds.), Wiley, Chichester, 1980, p. 315.
H.-K. Lim and E. J. Simon, Nature 271, 383 (1978).
W. F. Simonds, G. Koshi, R. A. Streaty, L. M. Hjelmeland, and W. A. Klee, Proc. Natl Acad. Sci. USA 77, 4623 (1980).
J. M. Bidlack, L. G. Abood, P. Osei-Gyimah, and S. Archer, Proc. Natl. Acad. Sci. USA 78, 638 (1981).
J. M. Bidlack and L. G. Abood, Life Sci. 27, 331 (1980).
P. Osei-Gyimah and S. Archer, J. Med. Chem. 23, 162 (1982).
S. Archer, A. Seyed-Mozaffari, P. Osei-Gyimah, J. M. Bidlack, and L. G. Abood, J. Med. Chem. 26, 1775 (1983).
J. M. Bidlack, private communication.
T. L. Gioannini, R. D. Howells, J. M. Hiller, and E. J. Simon, Life Sci. 31, 1315 (1982).
P. L. Kilian, D. Mullikin-Kilpatrick, and A. J. Blume, Life Sci. 31, 1319 (1982).
Y. Itzhak, J. M. Hiller, T. L. Goannini, and E. J. Simon, Life Sci. Suppl. 33, 1, 191 (1983).
Ph. Jauzac, A. Puget, and J. C. Meunier, Life Sci. Suppl. 1, 33, 195 (1983). A Peiffer, Life Sci. Suppl. 1,33,203 (1983).
B. R. Baker, Design of Active-Site-Directed Irreversible Enzyme Inhibitors, Wiley, New York (1967).
L. A. Cohen, Ann. Rev. Biochem. 37, 695, (1968).
J. F. Moran and D. J. Triggle, in: Fundamental Concepts in Drug-Receptor Interactions (J. F. Danielli, J. F. Moran, and D. J. Triggle, eds.), Academic Press, New York (1970).
P. S. Portoghese, R. N. Hanson, V. G. Telang, J. L. Winger, and A. E. Takemori, J. Med. Chem. 20, 1020 (1977).
P. S. Portoghese, D. L. Larson, J. B. Jiang, A. E. Takemori, and T. P. Caruso, J. Med. Chem. 21, 598 (1978).
P. S. Portoghese, D. L. Larso, J. B. Jiang, T. P. Caruso, and A. E. Takemori, J. Med. Chem. 22, 168 (1979).
T. P. Caruso, D. L. Larson, P. S. Portoghese, and A. T. Takemori, Life Sci. 27, 2063 (1980).
L. M. Sayre, A. E. Takemori, and P. S. Portoghese, J. Med. Chem. 26, 503 (1983).
P. S. Portoghese, D. L. Larson, L. M. Sayre, D. S. Fries, and A. E. Takemori, J. Med. Chem. 23, 233 (1980).
A. E. Takemori, D. L. Larson, and P. S. Portoghese, Eur. J. Pharmacol 70, 445 (1981).
L. M. Sayre, D. L. Larson, D. S. Fries, A. E. Takemori, and P. S. Portoghese, J. Med. Chem. 26, 1229 (1983).
P. S. Portoghese and A. E. Takemori, in: Chemical Regulation of Biological Mechanisms (A. M. Creighton and S. Turner, eds.), p. 181, Royal Society of Chemistry, London (1982).
P. S. Portoghese and A. E. Takemori, J. Med. Chem. 26, 1341 (1983).
K. C. Rice, A. E. Jacobson, T. R. Burke Jr., B. S. Bajwa, R. A. Streaty, and W. A. Klee, Science 220, 314 (1983).
A. E. Jacobson, B. S. Bajwa, R. A. Streaty, W. A. Klee, and K. C. Rice, Life Sci. 33, Suppl. 1. 159 (1983).
W. A. Klee, W. F. Simonds, F. W. Sweat, T. R. Burke, Jr., A. E. Jacobson, and K. C. Rice, FEBS Lett. 150, 125 (1982).
M. Smolarsky, and D. E. Koshland, Jr., J. Biol Chem. 255, 7244 (1980).
C. Zioudrou, D. Varoucha, S. Loukas, R. A. Streaty, and W. A. Klee, Life Sci. 31, 1671 (1982).
M. E. Lewis, H. Khachaturian, and S. J. Watson, Life Sci. 31, 1347 (1982).
C. Zioudron, D. Varoucha, S. Loukas, R. A. Streaty, and W. A. Klee, Life Sci. 31, 1671 (1982).
C. Garbay-Jaureguiberry, A. Robichon, and B. P. Roques, Life Sci. Suppl. 1, 33, 247 (1983).
V. M. Kolb, A. Koman, and L. Terenius, Life Sci. Suppl. 1, 33, 423 (1983).
M. Szücs, K. Di Gleria, and K. Medzihradszky, Life Sci. Suppl. 1, 33, 435 (1983).
E. M. Peers, M. J. Rance, E. A. Barnard, A. S. Haynes, and CF. Smith, Life Sci. Suppl. 1, 33, 439 (1983).
P. S. Portoghese, J. Med. Chem. 8, 609 (1965).
J. Di Maio, F. R. Ahmed, P. Schiller, and B. Belleau, in: Recent Advances in Receptor Chemistry (F. Gaultieri, M. Giannella, and C. Melchiorre, eds.), p. 221, Elsevier/North-Holland, Amsterdam (1979).
D. J. Triggle, Neurotransmitter-Receptor Interactions, p. 80, Academic Press, London (1971).
B. Belleau, private communication.
A. S. V. Burgen, G. C. K. Roberts, and J. Feeney, Nature 253, 753 (1975).
J. A Vida, C. M. Samour, M. H. O’Dea, T. S. T. Wang, and J. F. Reinhard, J. Med. Chem. 18, 694 (1975).
L. S. Melvin, M. Ross Johnson, C. A. Harbert G. M. Milne, and A. Weissman, J. Med. Chem. 27, 67 (1984).
C. G. Farmilo, P. M. Oestreicher, and L. Levi, Bull. Narcotics 6, 7 (1954).
A. F. Casy, M. M. A. Hassan, P. Pocha, and D. Staniforth, unpublished results.
P. S. Portoghese and D. A. Williams, J. Med. Chem. 12, 839 (1969).
A. F. Casy and J. Wright, J. Pharm. Pharmacol. 18, 677 (1966).
J. J. Kaufman, N. M. Semo, and W. S. Koski, J. Med. Chem. 18, 647 (1975).
A. Albert, Selective Toxicity, 4th ed., Methuen, London (1968).
A. H. Beckett and A. F. Casy, J. Pharm. Pharmacol 6, 986 (1954).
A. H. Beckett, J. Pharm. Pharmacol 8, 848 (1950).
P. S. Farmer, in: Drug Design (E. J. Ariens, ed.), Vol. X, p. 134, Academic Press, New York (1980).
L. B. Kier, J. Med. Chem. 11, 441 (1968).
R. S. Foster, D. J. Jenden, and P. Lomax, J. Pharmacol. Exp. Ther. 157, 185 (1967).
E. Kutter, A. Herz, H.-J. Teschemacher, and R. Hess, J. Med. Chem. 13, 801 (1970).
B. Belleau, T. Conway, F. R. Ahmed, and A. D. Hardy, J. Med. Chem. 17, 907 (1974).
G. N. Walker and D. Alkalay, J. Org. Chem. 36, 491 (1971).
F. R. Ahmed, Acta Cryst. B37, 188 (1981).
S. Shiotani, T. Kometani, Y. Litaka, and A. Itai, J. Med. Chem. 21, 153 (1978).
A. Herz and H.-J. Teschemacher, Adv. Drug Res. 6, 79 (1971).
K. E. Opheim and B. M. Cox, J. Med. Chem. 19, 857 (1977).
R. J. Kobylecki, A. C. Lane, C. F. C. Smith, L. P. G. Wakelin, W. B. T. Cruse, E. Egert, and O. Kennard, J. Med. Chem. 25, 1280 (1982).
A. Bianchetti, D. Nisato, R. Sacilotto, M. Dragonetti, N. Picerno, A. Tarantino, L. Manara, L. M. Angel, and E. J. Simon, Life Sci. 33, Suppl. 1., 415 (1983).
B. Belleau, V. Gulini, B. Gour-Salin, R. Camicioli, S. Lemaire, and F. Jolicoeur, in press.
B. Belleau, U. Gulini, B. Goar-Salin and F. R. Ahmed, Can. J. Chem. 63, 1268 (1985).
T. W. Smith, P. Buchan, D. N. Parsons, and S. Wilkinson, Life Sci. 31, 1205 (1982).
L. Rios and J. J. C. Jacob, Life Sci. 31, 1209 (1982).
K. Ramabadran, Life Sci. 31, 1271 (1982).
L. Manara, G. Bianchi, R. Fiocchi, A. Notarnicola, F. Perachia, and A. Tavani, Life Sci. 31, 1271 (1982).
A. Bianchetti, A. Giudice, N. Pierno, and P. Carminati, Life Sci. 31, 2261 (1982).
A. Mazzeo-Farina, and V. Frigeni, Eur. J. Med. Chem. 19, 11 (1984).
C. Elison, H. W. Elliott, M. Look, and H. Rapoport, J. Med. Chem. 6, 237 (1963).
B. Belleau, J. Burba, M. Pindell, and J. Reiffenstein, Science 133, 102 (1961).
V. M. Kolb and S. Scheiner, J. Pharm. Sci. 73, 389 (1984).
L. D. Simon, F. R. Simon, E. Mohasci, L. Berger, and E. J. Simon, Life Sci. 28, 2771 (1981).
P. S. Portoghese, J. Med. Chem. 8, 609 (1965).
A. F. Feinberg, I. Creese, and S. H. Snyder, Proc. Natl. Acad. Sci. USA 73, 4215 (1976).
E. L. Eliel, S. Morris-Natschke, and V. M. Kolb, Org. Magn. Reson. 22, 258 (1984).
V. M. Kolb, J. Pharm. Sci. 67, 999 (1978).
R. H. B. Galt, J. Pharm. Pharmacol. 29, 711 (1977).
D. S. Fries and P. S. Portoghese, J. Med. Chem. 19, 1155 (1976).
P. A. J. Janssen and N. B. Eddy, J. Med. Pharm. Chem. 2, 31 (1960).
N. B. Eddy, H. Besendorf, and B. Pellmont, Bull. Narcotics 10, 23 (1958).
E. Elpern, L. N. Gardner, and L. Grumbach, J. Am. Chem. Soc. 79, 1951 (1957).
B. Elpern, P. Carabateas, A. E. Soria, and L. Grumbach, J. Am. Chem. Soc. 81, 3784 (1959).
M. Froimowitz, P. Salva, G. J. Hite, G. Gianutsos, P. Suzdak, and R. Heyman, J. Comput. Chem. 5, 291 (1984).
E. Ohki, S. Oida, Y. Ohashi, H. Takagi, and I. Iwai, Chem. Pharm. Bull. 18, 2050 (1970).
C. Humblet and G. R. Marshall, Drug Devel. Res. 1, 409 (1981).
D. Lednicer and P. F. Von Voigtlander, J. Med. Chem. 22, 1158 (1979).
A. S. Horn and J. R. Rodgers, Nature 260, 795 (1970).
B. E. Maryanoff and M. J. Zelesko, J. Pharm. Sci. 67, 590 (1978).
K. Ramakrishna and P. S. Portoghese, J. Med. Chem. 25, 1423 (1982).
A. F. Bradbury, D. G. Smyth, and C. R. Snell, Nature 260, 165 (1976).
C. W. Hutchins and H. Rapoport, J. Med. Chem. 27, 521 (1984).
F. A. Gorin and G. R. Marshall, Proc. Natl. Acad. Sci. USA 74, 5179 (1977).
F. A. Gorin, T. M. Balasubramanian, C. D. Barry, and G. R. Marshall, J. Supramolec. Struct. 9, 27 (1978).
H. O. J. Collier and A. C. Roy, Nature 248, 24 (1974).
H. O. J. Collier, Nature 283, 625 (1980).
S. K. Sharma, M. Nirenberg, and W. A. Klee, Proc. Natl. Acad. Sci. 72, 590 (1975).
W. A. Klee and M. Nirenberg, Nature 263, 609 (1976).
J.-K. Chang and P. Cuatrecasas, J. Biol. Chem. 254, 2610 (1979).
G. Koski, R. A. Streaty, and W. A. Klee, J. Biol. Chem. 257, 14035 (1982).
P. Y. Law, D. S. Horn, and H. H. Loh, Molec. Pharmacol. 23, 26 (1983).
W. D. Bowen, S. Gentleman, M. Herkenham, and C. B. Pert, Proc. Natl. Acad. Sci. USA 78, 4818 (1981), and refs. there cited.
J. L. Vaught, R. B. Rothman, and T. C. Westfall, Life Sci. 30, 1443 (1982).
K.-J. Chang and P. Cuatrecasas, J. Biol. Chem. 254, 2610 (1979).
K.-J. Chang, B. R. Cooper, E. Hazum, and P. Cuatrecasas, Molec. Pharmacol. 16, 91 (1979).
R. B. Rothman and T. C. Westfall, Molec. Pharmacol. 21, 548 (1982).
N. M. Lee and A. P. Smith, Life Sci. 26, 1459 (1980).
R. B. Rothman, C. B. Pert, A. E. Jacobson, T. R. Burke, Jr., and K. C. Rice, Neuropeptides 4, 201 (1984).
J. P. Tollenaere, H. Moereels, and L. A. Raymaekers, in: X-Ray Crystallography and Drug Action (A. S. Horn and C. J. DeRanter, eds.), p. 461, Clarendon Press, Oxford (1984).
G. R. Marshall, in Ref. 101, p. 484.
W. G. Richards, Quantum Pharmacology, 2nd ed., p. 255, Butterworths, London (1983).
M. Foimowitz, J. Med. Chem. 25, 689, 1127 (1982).
M. Foimowitz, J. Med. Chem. 27, 1234 (1984).
J. P. Tollenaere, H. Moereels, and L. A. Raymaekers, in: Drug Design (E. J. Ariens, ed.), Vol. X, p. 71, Academic Press, New York (1980).
P. Gund, J. D. Andose, J. B. Rhodes, and G. M. Smith, Science 208, 1425 (1980).
E. F. Meyer, Jr., in: Drug Design (E. J. Ariens, ed.), Vol. IX, p. 267, Academic Press, New York (1980).
W. Kullmann, J. Med. Chem. 27, 106 (1984).
Martindale: The Extra Pharmacopoeia, 28th ed., Vol. XXIV. The Pharmaceutical Press, London (1982).
J. I. DeGraw, J. A. Lawson, J. L. Crase, H. L. Johnson, M. Ellis, E. T. Vyeno, G. H. Loeward, D. S. Berkowitz, J. Med. Chem. 21, 415 (1978).
P. S. Portoghese, B. D. Alreya, and D. L. Larson, J. Med. Chem. 24, 782 (1981).
T. P. Caruso, A. E. Takemori, D. L. Larson, and P. S. Portoghese, Science 204, 316 (1979).
L. M. Sayre, D. L. Larson, A. E. Takemori, and P. S. Portoghese, J. Med. Chem. 27, 1325 (1984).
S. Archer, J. Michael, M. Michael, E. J. Simon, E. M. E. Abdelhamid, W. L. Nelson, and G. A. Koolpe, paper presented at INRC meeting, Cambridge, U. K. July 1984.
W. Nelson, T. Gioannini, L. Angel, and E. J. Simon, J. Med. Chem., 27, (117), 1718 (1984).
S. Archer, J. Michael, P. Osei-Gyimah, R. S. Zukin, R. Maneckjee, E. J. Simon, and T. L. Gioannini, paper presented INRC meeting, Cambridge, U. K., July 1984.
R. Maneckjee, R. S. Zukin, S. Archer, J. Michael and P. Osei-Gyimah, Proc. Natl. Acad. Sci. USA, 82, 594 (1984).
G. A. Koolpe, W. Nelson, T. Gioannini, L. Angel, and E. J. Simon, J. Med. Chem. 27, 1718 (1984).
R. D. Howells, T. L. Gioannini, J. H. Hiller, and E. J. Simon, J. Pharmacol. Exp. Ther. 222, 629 (1982).
Y. Itzhak, J. H. Hiller, and E. J. Simon, Proc. Natl. Acad. Sci. USA, 81, 4217 (1984).
E. A. Barnard and C. Demoliou-Mason, Br. Med. Bull. 39, 37 (1983); J. Neurochem. in press.
T. T. Conway, T. W. Doyle, Y. G. Perron, J. Chapuis, and B. Belleau, Can. J. Chem. 53, 245 (1975).
J. DiMaio and B. Belleau, Can. J. Chem., 62, 2697 (1984).
B. Belleau, U. Gulini, and B. Gour-Salin, Can. J. Chem., in press.
V. M. Kolb and S. Scheiner, J. Pharm. Sci. 73, 719 (1984).
B. Belleau and P. Morgan, J. Med. Chem. 17, 908 (1974).
S. Fang, K. H. Bell, and P. S. Portoghese, J. Med. Chem. 27, 1090 (1984).
C. D. Demoliou-Mason and E. A. Barnard, FEBS Lett. 170, 378 (1984).
E. L. Newman and E. A. Barnard, Biochemistry 23, 5385 (1984).
R. E. West and R. J. Miller, Brit Med. Bull. 39, 53 (1983).
D. B. Chapman and E. L. Way, Ann. Rev. Pharmacol. Toxicol. 20, 553 (1980).
R. Franke, Theoretical Drug Design Methods (Pharmacochemistry Library, Vol. 7), Elsevier, Amsterdam (1984).
J. G. Vinter, Chem. Br. 21, 32 (1985).
C. H. Hassall, Chem. Br. 21, 39 (1985).
B. V. Cheney, D. J. Duchampand, and R. E. Christofferson, in: Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists and Hallucinogens (G. Barnett, M. Trsic, and R. E. Willette, eds.), p. 218, NIDA Res. Monograph 22, Rockville (1978).
R. A. Lessor, K. C. Rice, R. A. Streaty, W. A. Klee, and A. E. Jacobson, Neuropetides, in press.
M. Mishina, T. Kurosaki, T. Tobimatsu, Y. Morimoto, M. Noda, T. Yamamoto, M. Terao, J. Lindström, T. Takahashi, M. Kuno, and S. Numa, Nature 307, 604 (1984).
F. Porreca, H. I. Mosberg, R. Hurst, V. J. Hruby, and T. F. Burks, J. Pharmacol. Exp. Ther. 230, 341 (1984).
G. DeLander, P. S. Portoghese, and A. E. Takemori, J. Pharmacol. Exp. Ther. 231, 91 (1984).
G. S. F. Ling, K. Spiegel, S. L. Nishimura, and G. W. Pasternak, Eur. J. Pharmacol. 86, 487 (1983).
P. S. Portoghese, private communication.
A. Ullrich, J. R. Bell, E. Y. Chen, R. Herren, L. M. Petruzzelli, T. J. Dull, A. Gray, L. Coussens, Y.-C. Liao, M. Tsubokawa, A. Mason, P. H. Seeburg, C. Grunfeld, O. M. Rosen, and J. Ramachandran, Nature 313, 756 (1985).
J. A. Glasel and W. Reiher, Mag. Resort. Chem. 23, 236 (1985).
A. H. Beckett, A. F. Casy, and N. J. Harper, J. Pharm. Pharmacol. 8, 874 (1956).
E. F. Hahn, Med. Res. Rev. 5, 255 (1985) and references cited therein.
J. Reden, M. F. Reich, K. C. Rice, A. E. Jacobson, A. Brossi, R. A. Streaty, and W. A. Klee, J. Med. Chem. 22, 256 (1979).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Casy, A.F., Parfitt, R.T. (1986). Opioid Receptors: Facts and Speculations. In: Opioid Analgesics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0585-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0585-7_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0587-1
Online ISBN: 978-1-4899-0585-7
eBook Packages: Springer Book Archive